SCOPUS 정보 검색 플랫폼

Volumn 48, Issue 8, 2002, Pages 1360-1362

Serologic concentrations of HER-2/neu in breast cancer patients with visceral metastases receiving trastuzumab therapy predict the clinical course

(8) Schöndorf, Thomas a Hoopmann, Markus a Warm, Mathias a Neumann, Rainer a Thomas, Anke a Göhring, Uwe Jochen a Eisberg, Carsten a Mallmann, Peter a

a UNIVERSITY OF COLOGNE (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CA 15-3 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ONCOPROTEIN; TRASTUZUMAB; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; METASTASIS; ONCOGENE NEU; PREDICTION; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME;

EID: 0036325863 PISSN: 00099147 EISSN: None Source Type: Journal
DOI: 10.1093/clinchem/48.8.1360 Document Type: Article

Times cited : (30)

References (20)

1
- 37049183697
- Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
- (1987) Science , vol.235 , pp. 177-182
- Slamon, D.J.¹ Clark, G.M.² Wong, S.G.³ Levin, W.J.⁴ Ullrich, A.⁵ McGuire, W.L.⁶

2
- 0024337144
- Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
- (1989) Science , vol.244 , pp. 707-712
- Slamon, D.J.¹ Godolphin, W.² Jones, L.A.³ Holt, J.A.⁴ Wong, S.G.⁵ Keith, D.E.⁶

3
- 7344257734
- ErbB-2 protein in sera and tumors of breast cancer patients
- (1998) Breast Cancer Res Treat , vol.49 , pp. 261-270
- Breuer, B.¹ Smith, S.² Thor, A.³ Edgerton, S.⁴ Osborne, M.P.⁵ Minick, R.⁶

4
- 0026071364
- The extracellular domain of p185/neu is released from the surface of human breast carcinoma cells SK-BR-3
- (1991) J Biol Chem , vol.266 , pp. 1716-1720
- Zabrecky, J.R.¹ Lam, T.² McKenzie, S.J.³ Carney, W.⁴

5
- 0023430930
- Increase expression of the putative growth factor receptor p185HER-2 causes transformation and tumorigenesis of NIH 3T3 cells
- (1987) Proc Natl Acad Sci U S A , vol.84 , pp. 7159-7163
- Hudziak, R.M.¹ Schlessinger, J.² Ullrich, A.³

6
- 0026610881
- Humanization of an anti-p185HER-2 antibody for human cancer therapy
- (1992) Proc Natl Acad Sci U S A , vol.89 , pp. 4285-4289
- Carter, P.¹ Presta, L.² Gorman, C.M.³ Ridgway, J.B.⁴ Henner, D.⁵ Wong, W.L.⁶

7
- 0033118889
- Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers
- (1999) Oncogene , vol.18 , pp. 2241-2251
- Pegram, M.¹ Hsu, S.² Lewis, G.³ Pietras, R.⁴ Beryt, M.⁵ Sliwkowski, M.⁶

8
- 0035869407
- Use of chemotherapy plus a monoclonal antibody against HER-2 for metastatic breast cancer that overexpress HER-2
- (2001) N Engl J Med , vol.344 , pp. 783-792
- Slamon, D.J.¹ Leyland-Jones, B.² Shak, S.³ Fuchs, H.⁴ Paton, V.⁵ Bajamonde, A.⁶

9
- 0032850677
- Multinational study of the efficacy and safety of humanized anti-HER-2 monoclonal antibody in women who have HER-2 overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease
- (1999) J Clin Oncol , vol.17 , pp. 2639-2648
- Cobleigh, M.A.¹ Vogel, C.L.² Tripathy, D.³ Robert, N.J.⁴ Scholl, S.⁵ Fehrenbacher, L.⁶

10
- 0032078876
- Erb-B-2 oncogene in human breast cancer and its clinical significance
- (1998) Eur J Cancer , vol.34 , pp. 791-808
- Révillion, F.¹ Bonneterre, J.² Peyrat, J.P.³

11
- 0034518668
- Monitoring therapy by serum HER-2/neu
- (2001) Int J Biol Markers , vol.15 , pp. 324-329
- Schwartz, M.K.¹ Smith, C.² Schwartz, D.C.³ Dnistrian, A.⁴ Neiman, I.⁵

12
- 0034813368
- Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and leukemia group B study 8662
- (2001) Clin Cancer Res , vol.7 , pp. 2703-2711
- Hayes, D.F.¹ Yamauchi, H.² Broadwater, G.³ Cirricone, C.T.⁴ Rodrigue, S.P.⁵ Berry, D.A.⁶

13
- 0033968114
- Automated assay for HER-2/neu in serum
- (2000) Clin Chem , vol.46 , pp. 175-182
- Payne, R.C.¹ Allard, J.W.² Anderson-Mauser, L.³ Humphreys, J.D.⁴ Tenney, D.Y.⁵ Morris, D.L.⁶

14
- 0035868650
- Comparison of methods of measuring HER-2 in metastatic breast cancer patients treated with high-dose chemotherapy
- (2001) J Clin Oncol , vol.19 , pp. 1698-1706
- Harris, L.N.¹ Liotcheva, V.² Broadwater, G.³ Ramirez, M.J.⁴ Maimonis, P.⁵ Anderson, S.⁶

15
- 0031048153
- Influence of circulating c-erbB-2 serum protein on response to adjuvant chemotherapy in node-positive breast cancer patients
- (1997) Breast Cancer Res Treat , vol.43 , pp. 87-95
- Fehm, T.¹ Maimonis, P.² Weitz, S.³ Teramoto, Y.⁴ Katalinic, A.⁵ Jäger, W.⁶

16
- 0034691610
- Combined measurement of the c-erb-B-2 protein in breast carcinoma tissues and sera is useful as a sensitive tumor marker for monitoring tumor relapse
- (2000) Int J Cancer , vol.89 , pp. 329-336
- Sugano, K.¹ Ushiama, M.² Fukutomi, T.³ Tsuda, H.⁴ Kitph, T.⁵ Ohkura, H.⁶

17
- 0035000489
- Clinical utility of serum HER-2/neu testing on the Bayer Immuno 1 automated system in breast cancer
- (2001) Anticancer Res , vol.21 , pp. 1465-1470
- Cook, G.B.¹ Neaman, I.E.² Goldblatt, J.L.³ Cambetas, D.R.⁴ Hussain, M.⁵ Lüftner, D.⁶

18
- 0025864685
- Detection and quantitation of the human neu oncoprotein
- (1991) J Tumor Marker Oncol , vol.6 , pp. 53-72
- Carney, W.P.¹ Hamer, P.J.² Petit, D.³ Retos, C.⁴ Greene, R.⁵ Zabrecky, J.R.⁶

19
- 0028136611
- Serum levels of c-erb-B-2 protein in digestive diseases
- (1994) J Gastroenterol , vol.29 , pp. 616-620
- Motoo, Y.¹ Sawabu, N.² Yamaguchi, Y.³ Mouri, I.⁴ Yamakawa, O.⁵ Watanabe, H.⁶

20
- 0030925133
- Serum levels of C-erbB-2 (HER-2/neu) in patients with malignant and non-malignant diseases
- (1997) Tumour Biol , vol.18 , pp. 188-196
- Molina, R.¹ Jo, J.² Filella, X.³ Bruix, J.⁴ Castells, A.⁵ Hague, M.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.